Arcus Biosciences (RCUS) Insider Trading & Ownership → A new way to collect income from stocks (From DTI) (Ad) Free rcus Stock Alerts $15.62 +0.07 (+0.45%) (As of 04/29/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Arcus Biosciences (NYSE:RCUS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.80%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$339.45 MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$3.42 M Get RCUS Insider Trade Alerts Want to know when executives and insiders are buying or selling Arcus Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RCUS Insider Buying and Selling by Quarter Ad Wall Street StarAI finds its first serious applicationAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Arcus Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/27/2024Jennifer JarrettCOOSell11,551$17.55$202,720.05 3/18/2024Jennifer JarrettCOOSell13,449$17.92$241,006.08 2/26/2024Jennifer JarrettCOOSell24,555$20.07$492,818.85 2/26/2024Juan C JaenPresidentSell3,900$20.06$78,234.00 1/29/2024Gilead Sciences, Inc.Major ShareholderBuy15,238,095$21.00$319,999,995.00 1/2/2024Juan C JaenPresidentSell6,975$20.09$140,127.75 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/2/2024Robert C Goeltz IICFOSell2,004$20.00$40,080.00 12/22/2023Jennifer JarrettCOOSell21,521$17.76$382,212.96 9/22/2023Jennifer JarrettCOOSell21,369$19.99$427,166.31 7/28/2023Jennifer JarrettCOOSell45,000$20.25$911,250.00 7/3/2023Alexander AzoyCAOSell1,018$20.41$20,777.38 6/28/2023Gilead Sciences, Inc.Major ShareholderBuy1,010,000$19.26$19,452,600.00 6/22/2023Jennifer JarrettCOOSell12,437$19.12$237,795.44 6/16/2023Jennifer JarrettCOOSell12,563$19.35$243,094.05 (Data available from 1/1/2013 forward) RCUS Insider Trading Activity - Frequently Asked Questions Who is on Arcus Biosciences's Insider Roster? The list of insiders at Arcus Biosciences includes Alexander Azoy, Carolyn C Tang, Gilead Sciences, Inc., Jennifer Jarrett, Juan C Jaen, Robert C Goeltz II, and Terry J Rosen. Learn more on insiders at RCUS. What percentage of Arcus Biosciences stock is owned by insiders? 13.80% of Arcus Biosciences stock is owned by insiders. Learn more on RCUS's insider holdings. Which Arcus Biosciences insiders have been buying company stock? The following insider purchased RCUS shares in the last 24 months: Gilead Sciences, Inc. ($339,452,595.00). How much insider buying is happening at Arcus Biosciences? Insiders have purchased a total of 16,248,095 RCUS shares in the last 24 months for a total of $339,452,595.00 bought. Which Arcus Biosciences insiders have been selling company stock? The following insiders have sold RCUS shares in the last 24 months: Alexander Azoy ($20,777.38), Carolyn C Tang ($106,590.25), Jennifer Jarrett ($4,257,837.61), Juan C Jaen ($403,108.51), Robert C Goeltz II ($115,509.75), and Terry J Rosen ($488,945.77). How much insider selling is happening at Arcus Biosciences? Insiders have sold a total of 251,040 Arcus Biosciences shares in the last 24 months for a total of $5,392,769.27 sold. More Insider Trading Tools from MarketBeat Related Companies: ANI Pharmaceuticals Insider Buying Kura Oncology Insider Buying Morphic Insider Buying Akero Therapeutics Insider Buying Day One Biopharmaceuticals Insider Buying Edgewise Therapeutics Insider Buying Ardelyx Insider Buying Zai Lab Insider Buying Ironwood Pharmaceuticals Insider Buying Dynavax Technologies Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NYSE:RCUS) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryWhy Big Pharma is Investing Billions in This BiotechBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.